Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 |
| 10-K | 10-K | 10-K | 10-K |
Total revenues [+] | 66.4 | 70.2 | 47.5 | 63.6 |
Products | 65.6 | 69.4 | | |
Revenue growth | -5.4% | 47.7% | -25.2% | |
Cost of goods sold | 33.0 | 33.9 | 23.4 | 28.8 |
Gross profit | 33.5 | 36.3 | 24.1 | 34.8 |
Gross margin | 50.4% | 51.7% | 50.7% | 54.7% |
Selling, general and administrative [+] | 17.2 | 15.6 | 13.0 | 15.4 |
Sales and marketing | 9.8 | 9.2 | 7.5 | 8.8 |
General and administrative | 7.3 | 6.5 | 5.5 | 6.6 |
Research and development | 18.3 | 17.0 | | |
Other operating expenses | | | 11.2 | 12.8 |
EBITDA [+] | 0.8 | 5.8 | 2.1 | 9.1 |
EBITDA growth | -86.2% | 177.0% | -77.0% | |
EBITDA margin | 1.2% | 8.2% | 4.4% | 14.3% |
Depreciation | 2.5 | 1.8 | 1.9 | 1.9 |
EBITA | -1.7 | 4.0 | 0.2 | 7.2 |
EBITA margin | -2.6% | 5.6% | 0.5% | 11.4% |
Amortization of intangibles | 0.3 | 0.3 | 0.3 | 0.6 |
EBIT [+] | -2.0 | 3.7 | -0.1 | 6.6 |
EBIT growth | -153.5% | -6723.2% | -100.8% | |
EBIT margin | -3.0% | 5.3% | -0.1% | 10.4% |
Non-recurring items [+] | | | 6.2 | |
Asset impairment | | | 5.4 | |
Interest income, net [+] | -0.8 | -0.8 | -0.4 | 5.5 |
Interest expense | 0.8 | 0.8 | 0.4 | 0.4 |
Interest income | | | | 5.9 |
Other income (expense), net | 0.0 | -0.4 | 0.2 | -6.3 |
Pre-tax income | -2.8 | 2.5 | -6.4 | 5.9 |
Income taxes | -1.0 | 0.9 | -0.6 | 2.2 |
Tax rate | 36.7% | 37.0% | 9.6% | 38.0% |
Net income | -1.8 | 1.6 | -5.8 | 3.7 |
Net margin | -2.6% | 2.3% | -12.3% | 5.8% |
|
Basic EPS [+] | ($0.06) | $0.06 | ($0.22) | $0.14 |
Growth | -199.3% | -127.0% | -256.3% | |
Diluted EPS [+] | ($0.06) | $0.06 | ($0.22) | $0.13 |
Growth | -203.3% | -125.9% | -263.4% | |
|
Shares outstanding (basic) [+] | 30.3 | 27.1 | 26.8 | 26.4 |
Growth | 11.7% | 0.9% | 1.9% | |
Shares outstanding (diluted) [+] | 30.3 | 28.2 | 26.8 | 27.6 |
Growth | 7.5% | 4.9% | -2.6% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|